192 related articles for article (PubMed ID: 31156028)
21. Strategy for comprehensive identification of post-translational modifications in cellular proteins, including low abundant modifications: application to glyceraldehyde-3-phosphate dehydrogenase.
Seo J; Jeong J; Kim YM; Hwang N; Paek E; Lee KJ
J Proteome Res; 2008 Feb; 7(2):587-602. PubMed ID: 18183946
[TBL] [Abstract][Full Text] [Related]
22. Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles-Part 2: Mass spectrometric methods.
Reusch D; Haberger M; Falck D; Peter B; Maier B; Gassner J; Hook M; Wagner K; Bonnington L; Bulau P; Wuhrer M
MAbs; 2015; 7(4):732-42. PubMed ID: 25996192
[TBL] [Abstract][Full Text] [Related]
23. Two-Dimensional Mass Spectrometry Analysis of IgG1 Antibodies.
Paris J; Morgan TE; Marzullo BP; Wootton CA; Barrow MP; O'Hara J; O'Connor PB
J Am Soc Mass Spectrom; 2021 Jul; 32(7):1716-1724. PubMed ID: 34152763
[TBL] [Abstract][Full Text] [Related]
24. An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations.
Vafa O; Gilliland GL; Brezski RJ; Strake B; Wilkinson T; Lacy ER; Scallon B; Teplyakov A; Malia TJ; Strohl WR
Methods; 2014 Jan; 65(1):114-26. PubMed ID: 23872058
[TBL] [Abstract][Full Text] [Related]
25. Characterization of IgG1 immunoglobulins and peptide-Fc fusion proteins by limited proteolysis in conjunction with LC-MS.
Kleemann GR; Beierle J; Nichols AC; Dillon TM; Pipes GD; Bondarenko PV
Anal Chem; 2008 Mar; 80(6):2001-9. PubMed ID: 18293943
[TBL] [Abstract][Full Text] [Related]
26. Qualification of a Quantitative Method for Monitoring Aspartate Isomerization of a Monoclonal Antibody by Focused Peptide Mapping.
Cao M; Mo WD; Shannon A; Wei Z; Washabaugh M; Cash P
PDA J Pharm Sci Technol; 2016 11/12; 70(6):490-507. PubMed ID: 27091886
[TBL] [Abstract][Full Text] [Related]
27. Detection and Measurement of Methionine Oxidation in Proteins.
Sen KI; Hepler R; Nanda H
Curr Protoc Protein Sci; 2017 Feb; 87():14.16.1-14.16.11. PubMed ID: 28150882
[TBL] [Abstract][Full Text] [Related]
28. Selective Tryptophan Oxidation of Monoclonal Antibodies: Oxidative Stress and Modeling Prediction.
Pavon JA; Xiao L; Li X; Zhao J; Aldredge D; Dank E; Fridman A; Liu YH
Anal Chem; 2019 Feb; 91(3):2192-2200. PubMed ID: 30608647
[TBL] [Abstract][Full Text] [Related]
29. In vivo deamidation characterization of monoclonal antibody by LC/MS/MS.
Huang L; Lu J; Wroblewski VJ; Beals JM; Riggin RM
Anal Chem; 2005 Mar; 77(5):1432-9. PubMed ID: 15732928
[TBL] [Abstract][Full Text] [Related]
30. Understanding the Increased Aggregation Propensity of a Light-Exposed IgG1 Monoclonal Antibody Using Hydrogen Exchange Mass Spectrometry, Biophysical Characterization, and Structural Analysis.
Bommana R; Chai Q; Schöneich C; Weiss WF; Majumdar R
J Pharm Sci; 2018 Jun; 107(6):1498-1511. PubMed ID: 29408480
[TBL] [Abstract][Full Text] [Related]
31. Advantages of extended bottom-up proteomics using Sap9 for analysis of monoclonal antibodies.
Srzentić K; Fornelli L; Laskay ÜA; Monod M; Beck A; Ayoub D; Tsybin YO
Anal Chem; 2014 Oct; 86(19):9945-53. PubMed ID: 25207962
[TBL] [Abstract][Full Text] [Related]
32. Modulation of the effector functions of a human IgG1 through engineering of its hinge region.
Dall'Acqua WF; Cook KE; Damschroder MM; Woods RM; Wu H
J Immunol; 2006 Jul; 177(2):1129-38. PubMed ID: 16818770
[TBL] [Abstract][Full Text] [Related]
33. Structural analysis of intact monoclonal antibodies by electron transfer dissociation mass spectrometry.
Tsybin YO; Fornelli L; Stoermer C; Luebeck M; Parra J; Nallet S; Wurm FM; Hartmer R
Anal Chem; 2011 Dec; 83(23):8919-27. PubMed ID: 22017162
[TBL] [Abstract][Full Text] [Related]
34. A high-throughput UPLC method for the characterization of chemical modifications in monoclonal antibody molecules.
Stackhouse N; Miller AK; Gadgil HS
J Pharm Sci; 2011 Dec; 100(12):5115-25. PubMed ID: 21789770
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive Characterization of Relationship Between Higher-Order Structure and FcRn Binding Affinity of Stress-Exposed Monoclonal Antibodies.
Tsuchida D; Yamazaki K; Akashi S
Pharm Res; 2016 Apr; 33(4):994-1002. PubMed ID: 26694753
[TBL] [Abstract][Full Text] [Related]
36. A global comparability approach for biosimilar monoclonal antibodies using LC-tandem MS based proteomics.
Chen SL; Wu SL; Huang LJ; Huang JB; Chen SH
J Pharm Biomed Anal; 2013 Jun; 80():126-35. PubMed ID: 23563225
[TBL] [Abstract][Full Text] [Related]
37. Characterization of therapeutic monoclonal antibodies reveals differences between in vitro and in vivo time-course studies.
Yin S; Pastuskovas CV; Khawli LA; Stults JT
Pharm Res; 2013 Jan; 30(1):167-78. PubMed ID: 22956170
[TBL] [Abstract][Full Text] [Related]
38. Conformational studies of a monoclonal antibody, IgG1, by chemical oxidation: structural analysis by ultrahigh-pressure LC-electrospray ionization time-of-flight MS and multivariate data analysis.
Zamani L; Andersson FO; Edebrink P; Yang Y; Jacobsson SP
Anal Biochem; 2008 Sep; 380(2):155-63. PubMed ID: 18577369
[TBL] [Abstract][Full Text] [Related]
39. High-Resolution Mass Spectrometry to Identify and Quantify Acetylation Protein Targets.
Schilling B; Meyer JG; Wei L; Ott M; Verdin E
Methods Mol Biol; 2019; 1983():3-16. PubMed ID: 31087289
[TBL] [Abstract][Full Text] [Related]
40. Investigation of degradation processes in IgG1 monoclonal antibodies by limited proteolysis coupled with weak cation-exchange HPLC.
Lau H; Pace D; Yan B; McGrath T; Smallwood S; Patel K; Park J; Park SS; Latypov RF
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Apr; 878(11-12):868-76. PubMed ID: 20206584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
